Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Agents Report Back | Main | Wipe Down »

June 13, 2004

Dumpster Diving for Data?

Email This Entry

Posted by Derek

A comment to the last post wondered if drug companies ever do active intelligence against each other (as opposed to the passive kinds I mentioned). Active means would be rooting through dumpsters and the like, and the answer is - almost invariably - no.

That sort of thing is more trouble than it's worth, because it's easy to find out what's public knowledge at a given time and what isn't. If you dig around for nonpublic information, it doesn't do you much good unless you act on it. And if you act on it, you've admitted having something that you shouldn't, and you're faced with having to explain your psychic powers.

The same problem occurs in military and governmental intelligence gathering, on a rather larger scale. But there the theater the intelligence is gathered in is the same one where any repercussions will occur (in diplomatic relations or on the battlefield). In business, the retaliation will come through the courts, which is a completely different problem, and generally one you don't want.

If someone talks more than they should during a meeting, well, that's their problem. The listeners always have the defense that they didn't think that this was truly proprietary information, because if it was, the speaker wouldn't have let it out, right? But that said, I can't think of any major slip-ups of this kind - perhaps some of my readers know of a few.

The only active intelligence gathering I've heard was in a story that broke a few years ago. It seems that one or more large European pharma companies were trying to figure out what some of the patent-ignoring generic drug firms in Cyprus were up to, and hired some folks to sneak into some offices to see if their drugs were being pirated. A couple of people got caught in a break-in. I haven't seen a follow-up in some time, so I don't know what eventually happened. There was an interesting article in Fortune in 1998 or 1999 on the case, but it isn't online.

Comments (1) + TrackBacks (0) | Category: Drug Industry History


COMMENTS

1. Oliver Morton on June 27, 2004 8:05 AM writes...

I heard a rumour a few weeks ago that there had been suspicions that an oligonucleotide supplier was checking all its orders against Genbank, etc, to try and work out what targets various customers were aiming at. Does that sound either likely or profitable?

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Scripps Update
What If Drug Patents Were Written Like Software Patents?
Stem Cells: The Center of "Right to Try"
Speaking of Polyphenols. . .
Dark Biology And Small Molecules
How Polyphenols Work, Perhaps?
More On Automated Medicinal Chemistry
Scripps Merging With USC?